Codeine should not be prescribed for breastfeeding mothers or children under the age of 12

Moran Lazaryan1, Chen Shasha-Zigelman1, Zachi Dagan2

  • 1Pharmacy Department, Assaf Harofeh Medical Center, Zerifin, Sackler School of Medicine -Tel Aviv University, Tel-Aviv, Israel.

Insights

Codeine poses risks for children and breastfeeding mothers due to serious adverse events and uncertain effectiveness. Regulatory bodies now recommend against its use in these vulnerable populations.

Area of Science:

  • Pharmacology and Toxicology
  • Pediatric Medicine
  • Maternal Health

Background:

  • Regulatory authorities like the FDA and EMA have issued warnings concerning codeine use in pediatric patients and breastfeeding mothers.
  • Codeine's safety and efficacy in these specific populations have been questioned, prompting a review of existing data.

Purpose of the Study:

  • To explore the metabolic pathways and toxicological parameters of codeine in pediatric patients.
  • To investigate the implications of codeine use in breastfeeding mothers, focusing on infant exposure and effects.

Main Methods:

  • Systematic literature review of pharmacokinetic and pharmacodynamic studies.
  • Analysis of case reports and post-marketing surveillance data on codeine-related adverse events.
  • Evaluation of genetic polymorphisms affecting codeine metabolism.

Main Results:

  • Codeine metabolism varies significantly in children, leading to unpredictable plasma concentrations.
  • Serious adverse events, including respiratory depression, have been reported in pediatric populations.
  • Codeine transfer into breast milk can result in infant exposure, with potential for adverse effects.

Conclusions:

  • Given the risks of serious adverse events and questionable efficacy, codeine should not be prescribed for children under 12 years of age.
  • Codeine use is not recommended for breastfeeding mothers due to potential risks to the infant.
Abstract

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
896
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
360
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K